phelorphan has been researched along with phosphoramidon in 1 studies
| Studies (phelorphan) | Trials (phelorphan) | Recent Studies (post-2010) (phelorphan) | Studies (phosphoramidon) | Trials (phosphoramidon) | Recent Studies (post-2010) (phosphoramidon) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 781 | 12 | 33 |
| Protein | Taxonomy | phelorphan (IC50) | phosphoramidon (IC50) |
|---|---|---|---|
| Thermolysin | Bacillus thermoproteolyticus | 0.033 | |
| Neprilysin | Rattus norvegicus (Norway rat) | 0.0578 | |
| Neprilysin | Oryctolagus cuniculus (rabbit) | 0.0028 | |
| Neprilysin | Homo sapiens (human) | 0.0405 | |
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.615 | |
| Endothelin-converting enzyme 1 | Homo sapiens (human) | 1.0695 | |
| P2Y purinoceptor 12 | Homo sapiens (human) | 0.017 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dzoljic, MR | 1 |
1 other study(ies) available for phelorphan and phosphoramidon
| Article | Year |
|---|---|
Enkephalinase inhibitors attenuate naloxone-precipitated withdrawal syndrome.
Topics: Amino Acids, Sulfur; Animals; Cerebral Ventricles; Cerebrospinal Fluid; Dipeptides; Glycopeptides; Male; Metalloendopeptidases; Mice; Mice, Inbred Strains; Morphine Dependence; Naloxone; Neprilysin; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substance Withdrawal Syndrome; Thiorphan; Tiopronin | 1986 |